3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
10
Recruiting
3
Terminated
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
64
Lymphoid
13
Plasma cell
6
Classical hematology
4
Myeloid
3
Thoracic
2
Gastrointestinal
2
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
CNS
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
97
Head and Neck Neoplasms
89
Nasopharyngeal Carcinoma
54
Thyroid Neoplasms
29
Mouth Neoplasms
26
Thyroid Cancer, Papillary
15
Oropharyngeal Neoplasms
14
Neoplasm Metastasis
14
Laryngeal Neoplasms
13
Carcinoma, Squamous Cell
13
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
10
Uterine Cervical Neoplasms
8
Thyroid Nodule
8
Melanoma
8
Hypopharyngeal Neoplasms
8
Colorectal Neoplasms
8
Nasopharyngeal Neoplasms
7
Lung Neoplasms
7
Thyroid Diseases
5
Thyroid Carcinoma, Anaplastic
5
Sarcoma
5
Recurrence
5
Ovarian Neoplasms
5
Esophageal Neoplasms
5
Stomach Neoplasms
4
Salivary Gland Neoplasms
4
Parathyroid Neoplasms
4
Hyperparathyroidism, Primary
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Hematologic Neoplasms
×
Head & Neck
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled